Literature DB >> 8106380

Cholesterol movement from plasma membrane to rough endoplasmic reticulum. Inhibition by progesterone.

Y Lange1.   

Abstract

The effect of progesterone on the movement of sterols from the cell surface to the rough endoplasmic reticulum (ER) was examined in rat hepatoma cells. Plasma membranes were labeled exogenously with [3H]cholesterol or [3H]zymosterol. Translocation of the labeled sterols to the rough ER was inferred from their conversion to [3H]cholesteryl esters and [3H]cholesterol, respectively. Progesterone inhibited both of these reactions by more than 90%. The concentration for half-maximal inhibition was 0.7 microgram/ml. Progesterone did not inhibit acyl-CoA:cholesterol acyltransferase activity itself, since the steroid had no effect on the esterification of [3H]cholesterol synthesized in vitro in the rough ER from [3H]zymosterol. Moreover, the small amount of [3H]cholesterol synthesized from plasma membrane [3H]zymosterol in progesterone-treated intact cells was esterified at the same fractional rate as cholesterol in control cells. Subcellular fractionation of cells pulse-labeled with [3H]cholesterol and treated with progesterone suggested that the block in plasma membrane cholesterol transfer to the rough ER occurred at the level of the plasma membrane.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8106380

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  13 in total

1.  A cholesterol-regulated PP2A/HePTP complex with dual specificity ERK1/2 phosphatase activity.

Authors:  Ping-Yuan Wang; Pingsheng Liu; Jian Weng; Estelle Sontag; Richard G W Anderson
Journal:  EMBO J       Date:  2003-06-02       Impact factor: 11.598

2.  Secretory processing of amyloid precursor protein is inhibited by increase in cellular cholesterol content.

Authors:  M Racchi; R Baetta; N Salvietti; P Ianna; G Franceschini; R Paoletti; R Fumagalli; S Govoni; M Trabucchi; M Soma
Journal:  Biochem J       Date:  1997-03-15       Impact factor: 3.857

Review 3.  Regulation of intracellular signaling and function by caveolin.

Authors:  Heidi N Fridolfsson; David M Roth; Paul A Insel; Hemal H Patel
Journal:  FASEB J       Date:  2014-05-22       Impact factor: 5.191

4.  Multidrug resistance P-glycoprotein dampens SR-BI cholesteryl ester uptake from high density lipoproteins in human leukemia cells.

Authors:  Stefano Spolitu; Sabrina Uda; Stefania Deligia; Alessandra Frau; Maria Collu; Fabrizio Angius; Barbara Batetta
Journal:  Am J Cancer Res       Date:  2016-02-15       Impact factor: 6.166

Review 5.  Biochemical, genetic, and metabolic adaptations of tumor cells that express the typical multidrug-resistance phenotype. Reversion by new therapies.

Authors:  L G Baggetto
Journal:  J Bioenerg Biomembr       Date:  1997-08       Impact factor: 2.945

6.  Selective effect of cholesterylphosphoserine on intracellular cholesterol transport.

Authors:  F Cusinato; A Bruni
Journal:  Lipids       Date:  2002-01       Impact factor: 1.880

7.  Side chain oxygenated cholesterol regulates cellular cholesterol homeostasis through direct sterol-membrane interactions.

Authors:  Sarah E Gale; Emily J Westover; Nicole Dudley; Kathiresan Krishnan; Sean Merlin; David E Scherrer; Xianlin Han; Xiuhong Zhai; Howard L Brockman; Rhoderick E Brown; Douglas F Covey; Jean E Schaffer; Paul Schlesinger; Daniel S Ory
Journal:  J Biol Chem       Date:  2008-11-06       Impact factor: 5.157

8.  Alterations in the homeostasis of phospholipids and cholesterol by antitumor alkylphospholipids.

Authors:  José M Jiménez-López; Pablo Ríos-Marco; Carmen Marco; Josefa L Segovia; María P Carrasco
Journal:  Lipids Health Dis       Date:  2010-03-25       Impact factor: 3.876

Review 9.  Cellular cholesterol homeostasis in vascular endothelial cells.

Authors:  Hajj Hassan Hassan; Maxime Denis; Larbi Krimbou; Michel Marcil; Jacques Genest
Journal:  Can J Cardiol       Date:  2006-02       Impact factor: 5.223

10.  Molecular analysis of the multidrug transporter, P-glycoprotein.

Authors:  U A Germann; T C Chambers
Journal:  Cytotechnology       Date:  1998-09       Impact factor: 2.058

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.